ACR appropriateness criteria® ductal carcinoma in situ

Seth A. Kaufman, Eleanor E R Harris, Lisa Bailey, Manjeet Chadha, Sharon C. Dutton, Gary M. Freedman, Sharad Goyal, Michele Y. Halyard, Kathleen C. Horst, Kristina L M Novick, Catherine C. Park, W. Warren Suh, Deborah Toppmeyer, Jennifer Zook, Bruce G. Haffty

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

Original languageEnglish (US)
JournalONCOLOGY (United States)
Volume29
Issue number6
StatePublished - Jun 15 2015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'ACR appropriateness criteria® ductal carcinoma in situ'. Together they form a unique fingerprint.

  • Cite this

    Kaufman, S. A., Harris, E. E. R., Bailey, L., Chadha, M., Dutton, S. C., Freedman, G. M., Goyal, S., Halyard, M. Y., Horst, K. C., Novick, K. L. M., Park, C. C., Suh, W. W., Toppmeyer, D., Zook, J., & Haffty, B. G. (2015). ACR appropriateness criteria® ductal carcinoma in situ. ONCOLOGY (United States), 29(6).